Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorMutlu, Hasan
dc.contributor.authorBuyukcelik, Abdullah
dc.contributor.authorAkca, Zeki
dc.contributor.authorErden, Abdulsamet
dc.date.accessioned2025-10-16T15:31:40Z
dc.date.issued2015
dc.identifier.doi10.1177/1078155213508442
dc.identifier.otherWOS:000346997900008
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9049
dc.publisherSAGE PUBLICATIONS LTD
dc.sourceJOURNAL OF ONCOLOGY PHARMACY PRACTICE
dc.titleReversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS